Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan

International Journal of Antimicrobial Agents

Volumn 34, Issue 4, 2009, Pages 347-350

  Ode, Takashi ^a   Saito, Ryoichi ^b   Kumita, Wakako ^a   Sato, Kenya ^a   Okugawa, Shu ^b   Moriya, Kyoji ^b   Koike, Kazuhiko ^b   Okamura, Noboru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Aminoglycoside acetyltransferase; Class 1 integron; Extended spectrum lactamase; Metallo lactamase; qnr

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE CASSETTE; GENE INSERTION; GENE SEQUENCE; INTEGRON; JAPAN; KLEBSIELLA OXYTOCA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CONJUGATION, GENETIC; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INTEGRONS; JAPAN; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; MICROBIAL SENSITIVITY TESTS; PLASMIDS; QUINOLONES; SEQUENCE ANALYSIS, DNA;

EID: 67651204428     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.05.007     Document Type: Article

References (15)

1. Robicsek A., Jacoby G.A., and Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6 (2006) 629-640
2. Hata M., Suzuki M., Matsumoto M., Takahashi M., Sato K., Ibe S., et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 49 (2005) 801-803
3. Saga T., Akasaka T., Takase H., Tanaka M., Sato K., and Kaku M. First detection of the plasmid-mediated quinolone resistance determinant qnrA in Enterobacteriaceae clinical isolates in Japan. Int J Antimicrob Agents 29 (2007) 738-739
4. Saito R., Kumita W., Sato K., Chida T., Okamura N., Moriya K., et al. Detection of plasmid-mediated quinolone resistance associated with qnrA in an Escherichia coli clinical isolate producing CTX-M-9 β-lactamase in Japan. Int J Antimicrob Agents 29 (2007) 600-602
5. Yamane K., Wachino J., Suzuki S., and Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 52 (2008) 1564-1566
6. Wu J.J., Ko W.C., Tsai S.H., and Yan J.J. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother 51 (2007) 1223-1227
7. VIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy. J Antimicrob Chemother 61 (2008) 515-523
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. Document M100-S15. Wayne, PA: CLSI; 2005.
9. Yagi T., Kurokawa H., Shibata N., Shibayama K., and Arakawa Y. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 184 (2000) 53-56
10. Saladin M., Cao V.T., Lambert T., Donay J.L., Herrmann J.L., Ould-Hocine Z., et al. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209 (2002) 161-168
11. Shibata N., Doi Y., Yamane K., Yagi T., Kurokawa H., Shibayama K., et al. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by Gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol 41 (2003) 5407-5413
12. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., and Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50 (2006) 2872-2874
13. Park C.H., Robicsek A., Jacoby G.A., Sahm D., and Hooper D.C. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50 (2006) 3953-3955
14. Cambau E., Lascols C., Sougakoff W., Bébéar C., Bonnet R., Cavallo J.D., et al. Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005. Clin Microbiol Infect 12 (2006) 1013-1020
15. Lévesque C., Piché L., Larose C., and Roy P.H. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39 (1995) 185-191